314 related articles for article (PubMed ID: 36737790)
21. Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - Advances in diagnosis and prognostication.
Meredith DM; Alexandrescu S
Brain Pathol; 2022 Jul; 32(4):e13059. PubMed ID: 35266242
[TBL] [Abstract][Full Text] [Related]
22. Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.
Gojo J; Kjaersgaard M; Zezschwitz BV; Capper D; Tietze A; Kool M; Haberler C; Pizer B; Hoff KV
Eur J Med Genet; 2023 Jan; 66(1):104660. PubMed ID: 36356895
[TBL] [Abstract][Full Text] [Related]
23. DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.
Liu KX; Shang HH; Cacciotti C; Everdell E; Aizer AA; Rahman R; Malinowski S; Meredith DM; Kamihara J; Wen PY; Ligon KL; Chi SN; Marcus KJ; Yeo KK; Alexandrescu S; Haas-Kogan DA
J Neurooncol; 2022 May; 157(3):499-510. PubMed ID: 35384518
[TBL] [Abstract][Full Text] [Related]
24. World Health Organization Classification of Tumors of the Central Nervous System 5
Mahajan S; Suri V; Sahu S; Sharma MC; Sarkar C
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S5-S13. PubMed ID: 35562129
[TBL] [Abstract][Full Text] [Related]
25. An update on the central nervous system manifestations of DICER1 syndrome.
de Kock L; Priest JR; Foulkes WD; Alexandrescu S
Acta Neuropathol; 2020 Apr; 139(4):689-701. PubMed ID: 30953130
[TBL] [Abstract][Full Text] [Related]
26. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW
Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076
[TBL] [Abstract][Full Text] [Related]
27. Newly Recognized Genetic Tumor Syndromes of the CNS in the 5th WHO Classification: Imaging Overview with Genetic Updates.
Agarwal A; Bathla G; Soni N; Desai A; Ajmera P; Rao D; Gupta V; Vibhute P
AJNR Am J Neuroradiol; 2024 Feb; 45(2):128-138. PubMed ID: 37945522
[TBL] [Abstract][Full Text] [Related]
28. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant.
Alexandrescu S; Meredith DM; Lidov HG; Alaggio R; Novello M; Ligon KL; Vargas SO
Histopathology; 2021 Jan; 78(2):265-275. PubMed ID: 32692439
[TBL] [Abstract][Full Text] [Related]
29. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
30. DICER1-associated central nervous system sarcoma with neural lineage differentiation: a case report.
Yao K; Duan Z; Feng J; Yan C; Qi X
Diagn Pathol; 2022 Sep; 17(1):72. PubMed ID: 36153506
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic DNA methylome profiling and the WHO 5
Frank S; Hench J
Clin Neuropathol; 2022; 41(4):153-156. PubMed ID: 35670246
[TBL] [Abstract][Full Text] [Related]
32. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
33. Miscellaneous newly recognized types of CNS tumors in the WHO CNS5 classification (other than gliomas, glioneuronal and embryonal tumors).
Chatterjee D; Gupta K
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S94-S98. PubMed ID: 35562139
[TBL] [Abstract][Full Text] [Related]
34. Primary Intracranial Sarcoma, DICER1-Mutant Presenting as a Pineal Region Tumor Mimicking Pineoblastoma: Case Report and Review of the Literature.
Leelatian N; Goss J; Pastakia D; Dewan MC; Snuderl M; Mobley BC
J Neuropathol Exp Neurol; 2022 Aug; 81(9):762-764. PubMed ID: 35789272
[No Abstract] [Full Text] [Related]
35. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors.
Bertero L; Mangherini L; Ricci AA; Cassoni P; Sahm F
Virchows Arch; 2024 Feb; 484(2):181-194. PubMed ID: 37658995
[TBL] [Abstract][Full Text] [Related]
36. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
Miller DC
Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567
[TBL] [Abstract][Full Text] [Related]
37. Histopathologic "Evolution" in Pediatric Primary Intracranial High-Grade Sarcoma - a Key that Unlocked the Correct Diagnosis.
Naik U; Shah M; Sandberg DI; Samant R; Roy A; Bhattacharjee MB
Ann Clin Lab Sci; 2023 Jul; 53(4):661-666. PubMed ID: 37625831
[TBL] [Abstract][Full Text] [Related]
38. Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system.
Oztek MA; Noda SM; Romberg EK; Cole BL; Wright JN; Ishak GE; Perez FA
Pediatr Radiol; 2023 Mar; 53(3):523-543. PubMed ID: 36348014
[TBL] [Abstract][Full Text] [Related]
39. Two cases of primary supratentorial intracranial rhabdomyosarcoma with DICER1 mutation which may belong to a "spindle cell sarcoma with rhabdomyosarcoma-like feature, DICER1 mutant".
Sakaguchi M; Nakano Y; Honda-Kitahara M; Kinoshita M; Tanaka S; Oishi M; Noguchi K; Fukuda M; Maeba H; Watanabe T; Hayashi Y; Ikeda H; Minato H; Ichimura K; Nojima T; Nakada M
Brain Tumor Pathol; 2019 Oct; 36(4):174-182. PubMed ID: 31487013
[TBL] [Abstract][Full Text] [Related]
40. [Contributions and limitations of FISH analysis for the diagnosis of central nervous system tumors according to the 2021 WHO classification: Feedback from Sainte-Anne Hospital's Department of Neuropathology].
Tauziède-Espariat A; Tartar A; Mehdi L; Pucelle N; Lacombe J; Berthaud C; Brigot E; Massé J; Métais A; Benzakoun J; Hasty L; Chrétien F; Varlet P
Ann Pathol; 2023 Nov; 43(6):443-451. PubMed ID: 37385935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
